3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
6
Gastrointestinal
2
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
8
Neoplasms
2
Colonic Neoplasms
2
Rectal Neoplasms
1
Prostatic Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Female Breast Carcinoma
1
Female Breast Cancer
1
Interventions
pembrolizumab
19
Magnetic Resonance Spectroscopy
17
Docetaxel
13
Specimen Handling
12
Radiotherapy
11
Surveys and Questionnaires
10
Cyclophosphamide
10
Blood Specimen Collection
9
Radiosurgery
8
Paclitaxel
8
Gemcitabine
8
Drug Therapy
8
sargramostim
7
Trastuzumab
7
Nivolumab
7
Carboplatin
7
Injections
6
Early Intervention, Educational
6
Taxes
5
Psychiatric Rehabilitation
5
Methods
5
Interviews as Topic
5
Educational Status
5
spartalizumab
4
motexafin gadolinium
4
aldesleukin
4
X-Rays
4
Therapeutics
4
Standard of Care
4
Spinal Puncture
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Sevoflurane
×
Breast
×
Clear all
NCT04074460
2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4
Completed
169 enrolled